Tenet Healthcare (NYSE:THC) Releases Q3 2021 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its third quarter 2021 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.730-$1.060 for the period, compared to the Thomson Reuters consensus estimate of $1.060. The company issued revenue guidance of $4.60 billion-$4.80 billion, compared to the consensus revenue estimate of $4.88 billion.Tenet Healthcare also updated its FY 2021 guidance to $5.230-$5.730 EPS.

Shares of THC traded down $3.40 during midday trading on Thursday, reaching $68.85. 76,276 shares of the stock were exchanged, compared to its average volume of 910,219. Tenet Healthcare has a 12-month low of $21.34 and a 12-month high of $73.65. The business has a 50 day simple moving average of $66.97. The company has a debt-to-equity ratio of 14.86, a quick ratio of 1.28 and a current ratio of 1.36. The firm has a market cap of $7.35 billion, a P/E ratio of 19.37 and a beta of 2.61.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Tuesday, July 20th. The company reported $1.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.52. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.78 billion. Tenet Healthcare had a return on equity of 65.38% and a net margin of 2.25%. The business’s quarterly revenue was up 35.8% on a year-over-year basis. During the same period last year, the business earned $1.26 EPS. As a group, sell-side analysts predict that Tenet Healthcare will post 5.21 earnings per share for the current year.

A number of research analysts have recently commented on the company. Seaport Global Securities assumed coverage on Tenet Healthcare in a report on Friday, July 9th. They set a buy rating and a $80.00 price objective on the stock. Truist increased their price objective on Tenet Healthcare from $56.00 to $60.00 in a report on Thursday, April 22nd. Seaport Res Ptn reissued a buy rating on shares of Tenet Healthcare in a report on Friday, July 9th. Zacks Investment Research downgraded Tenet Healthcare from a buy rating to a hold rating and set a $72.00 target price for the company. in a research report on Tuesday, June 22nd. Finally, Credit Suisse Group raised their target price on Tenet Healthcare from $58.00 to $71.00 and gave the stock an outperform rating in a research report on Thursday, April 22nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the stock. Tenet Healthcare has an average rating of Buy and an average target price of $57.50.

In related news, EVP Howard Hacker sold 6,382 shares of the company’s stock in a transaction dated Friday, May 28th. The stock was sold at an average price of $66.70, for a total transaction of $425,679.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Meghan Fitzgerald sold 6,153 shares of the company’s stock in a transaction dated Monday, May 24th. The stock was sold at an average price of $63.57, for a total value of $391,146.21. Following the sale, the director now owns 33,828 shares in the company, valued at approximately $2,150,445.96. The disclosure for this sale can be found here. Over the last three months, insiders sold 21,197 shares of company stock valued at $1,371,540. Insiders own 1.60% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Read More: What is the return on assets formula?

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.